Drug recall · November 21, 2018
Alprostadil Injection USP 500 micrograms/mL 1 mL single use vial recall
Why: Failed Impurities/Degradation Specifications; out-of-specification results for impurities obtained during routine stability testing
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Alprostadil Injection USP 500 micrograms/mL 1 mL single use vial, 5 vials per carton, Rx only, TEVA Pharmaceuticals USA, Inc., North Wales, PA --- NDC 0703-1501-02
- Lots / codes
Lot # 31323147B, exp. date 01/2019
- Quantity
- 1,362 vials
- Company
- Teva Pharmaceuticals USA, North Wales, PA
- Distribution
- Product was distributed throughout the United States, including Hawaii and Puerto Rico.
- Initiated
- September 27, 2018 · Voluntary: Firm initiated
- Classified
- November 14, 2018
- Reported
- November 21, 2018
- Ended
- October 6, 2020
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Alprostadil
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.